BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26087192)

  • 21. Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma.
    de Souza DR; Sanabani SS; de Souza AC; Filho Odone V; Epelman S; Bendit I
    Pediatr Blood Cancer; 2011 May; 56(5):749-56. PubMed ID: 21154590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
    Malih S; Saidijam M; Malih N
    Tumour Biol; 2016 Feb; 37(2):1479-85. PubMed ID: 26662315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYCNOS functions as an antisense RNA regulating MYCN.
    Vadie N; Saayman S; Lenox A; Ackley A; Clemson M; Burdach J; Hart J; Vogt PK; Morris KV
    RNA Biol; 2015; 12(8):893-9. PubMed ID: 26156430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic markers for neuroblastoma risk estimation: superseding tumor stage, age and MYCN?
    Oberthuer A
    Biomark Med; 2013 Dec; 7(6):905-8. PubMed ID: 24266822
    [No Abstract]   [Full Text] [Related]  

  • 25. NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2.
    Hu P; Chu J; Wu Y; Sun L; Lv X; Zhu Y; Li J; Guo Q; Gong C; Liu B; Su S
    Oncotarget; 2015 Oct; 6(32):32410-25. PubMed ID: 26378045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma.
    Altungoz O; Aygun N; Tumer S; Ozer E; Olgun N; Sakizli M
    Cancer Genet Cytogenet; 2007 Jan; 172(2):113-9. PubMed ID: 17213019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
    Yang Z; Guo X; Li G; Shi Y; Li L
    Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-myc and noncoding RNAs in neuroblastoma.
    Buechner J; Einvik C
    Mol Cancer Res; 2012 Oct; 10(10):1243-53. PubMed ID: 22936790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNAs in cancer cells.
    Bach DH; Lee SK
    Cancer Lett; 2018 Apr; 419():152-166. PubMed ID: 29414303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of long noncoding RNA in neuroblastoma.
    Ye M; Liu B; Zhang J; Dong K
    Discov Med; 2020; 30(160):71-82. PubMed ID: 33382963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long Noncoding RNA NHEG1 Drives β-Catenin Transactivation and Neuroblastoma Progression through Interacting with DDX5.
    Zhao X; Li D; Yang F; Lian H; Wang J; Wang X; Fang E; Song H; Hu A; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q
    Mol Ther; 2020 Mar; 28(3):946-962. PubMed ID: 31982037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNAs in regulation of human breast cancer.
    Wang G; Liu C; Deng S; Zhao Q; Li T; Qiao S; Shen L; Zhang Y; Lü J; Meng L; Liang C; Yu Z
    Brief Funct Genomics; 2016 May; 15(3):222-6. PubMed ID: 26582840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNAs in head and neck cancer.
    Li X; Cao Y; Gong X; Li H
    Oncotarget; 2017 Feb; 8(6):10726-10740. PubMed ID: 27802187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.
    Chandra Gupta S; Nandan Tripathi Y
    Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNAs: emerging regulators of tumor angiogenesis.
    Sheng SR; Wu JS; Tang YL; Liang XH
    Future Oncol; 2017 Jul; 13(17):1551-1562. PubMed ID: 28513194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The MYCN oncogene and differentiation in neuroblastoma.
    Westermark UK; Wilhelm M; Frenzel A; Henriksson MA
    Semin Cancer Biol; 2011 Oct; 21(4):256-66. PubMed ID: 21849159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.
    Owens C; Irwin M
    Crit Rev Clin Lab Sci; 2012; 49(3):85-115. PubMed ID: 22646747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
    Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C
    Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNAs in prostate cancer: overview and clinical implications.
    Malik B; Feng FY
    Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of NLRR3 orphan receptor gene is negatively regulated by MYCN and Miz-1, and its downregulation is associated with unfavorable outcome in neuroblastoma.
    Akter J; Takatori A; Hossain MS; Ozaki T; Nakazawa A; Ohira M; Suenaga Y; Nakagawara A
    Clin Cancer Res; 2011 Nov; 17(21):6681-92. PubMed ID: 21908575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.